KNPAX
Price
$122.70
Change
+$0.58 (+0.47%)
Updated
Jul 25 closing price
Net Assets
1.21B
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

KNPAX vs PMAQX

Header iconKNPAX vs PMAQX Comparison
Open Charts KNPAX vs PMAQXBanner chart's image
Kinetics Paradigm Adv A
Price$122.70
Change+$0.58 (+0.47%)
VolumeN/A
Net Assets1.21B
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
KNPAX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KNPAX vs. PMAQX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNPAX is a Buy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. KNPAX (1.21B). PMAQX pays higher dividends than KNPAX: PMAQX (0.19) vs KNPAX (0.00). KNPAX was incepted earlier than PMAQX: KNPAX (24 years) vs PMAQX (9 years). KNPAX (1.91) is less costly to investors than PMAQX (0.59). PMAQX is a more actively managed with annual turnover of: 10.50 vs. KNPAX (2.00). PMAQX has a lower initial minimum investment than KNPAX: PMAQX (0) vs KNPAX (2500). KNPAX annual gain was more profitable for investors over the last year : 24.49 vs. PMAQX (13.16). KNPAX return over 5 years is better than : 189.27 vs. PMAQX (57.67).
KNPAXPMAQXKNPAX / PMAQX
Total Expense Ratio1.890.59320%
Annual Report Gross Expense Ratio1.910.59324%
Fund Existence24 years9 years-
Gain YTD-3.8507.977-48%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B33B4%
Annual Yield % from dividends0.000.19-
Returns for 1 year24.4913.16186%
Returns for 3 years57.4949.76116%
Returns for 5 years189.2757.67328%
Returns for 10 years269.30N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics